This is when new, abnormal blood vessels grow inside the cornea. This can happen after certain eye infections or inflammation, or sometimes after a cornea transplant. These new vessels can make the eye feel irritated or blurry.
Every report comes from a Lived member, sent anonymously.
Have you tried Lotemax (Loteprednol) for Corneal Neovascularization?
Corneal neovascularization is the growth of new blood vessels into the cornea, the clear dome at the front of the eye. A healthy cornea has no blood vessels at all, which is part of what keeps it transparent. When the eye is injured, infected, inflamed or starved of oxygen for a long time, vessels can sprout from the edge of the cornea (the limbus, where the clear cornea meets the white of the eye) and grow inward. It is a response to another eye problem rather than a disease on its own. Vessels near the edge may cause no noticeable change, but vessels that reach the center can blur vision by blocking light, leaking fat and protein that leave cloudy deposits, and leading to swelling and scarring. The vessels also matter for anyone who has had, or may need, a corneal transplant, because they make the immune system more likely to reject donor tissue.
Anything that keeps the cornea inflamed or short of oxygen can tip the balance toward vessel growth. Among the most common causes are wearing contact lenses for too long or overnight, especially soft lenses that let less oxygen through or fit poorly, and infections of the cornea (keratitis), with herpes simplex virus a frequent culprit. Others include eyelid inflammation, chemical burns, injuries, previous eye surgery, severe dry eye, chronic allergic eye disease and autoimmune conditions such as rheumatoid arthritis. A corneal transplant can also trigger vessel growth, particularly during a rejection episode or when healing is poor. Damage to the limbal stem cells, the cells at the edge of the cornea that renew its surface and help keep vessels out, is a major cause of severe and widespread vessel growth. Contact lens wearers are a recognized higher-risk group, which is one reason regular eye exams matter for them.
An eye doctor diagnoses corneal neovascularization by examining the eye with a slit lamp, a microscope with a bright, adjustable beam that shows the layers of the cornea in detail. The examination shows where the vessels start, how far and how deep they reach, whether they look new and active or mature and established, and whether they are leaking fat or causing swelling or scarring. Early vessel growth can be subtle, so it is often found during a routine exam or while the doctor is looking for the cause of a red or irritated eye. Because the vessels are a sign of an underlying problem, much of the assessment is aimed at finding that cause, for example checking for infection, reviewing contact lens habits or looking for signs of limbal stem cell damage. In some cases, especially before a transplant, the doctor may photograph the cornea or use a dye test (angiography) to map the vessels more precisely.
Treatment starts with the underlying cause: clearing an infection, controlling inflammation, treating dry eye or changing how contact lenses are worn. This matters because new, still-growing vessels depend on ongoing signals from the damaged eye and are far easier to stop or shrink than vessels that have been present for a long time. Mature vessels often remain even after the original problem is controlled. Steroid eye drops are a common first step because they calm the inflammation that drives vessel growth. Their trade-off is important: long-term use can raise pressure inside the eye (which can lead to glaucoma), cause cataracts, allow infections to take hold and reactivate herpes eye infections, so they need regular monitoring. Other drops, such as cyclosporine (an immune-calming medicine), are sometimes used as well. Another group of medicines blocks vascular endothelial growth factor (VEGF), a signal the eye releases that tells blood vessels to grow. Bevacizumab, the most studied, is given as eye drops or as a small injection under the thin clear membrane covering the white of the eye. In small studies it shrank the area covered by vessels by roughly a third on average, but improvements in vision were small and inconsistent. It works mainly on newer vessels, the effect wears off so treatment is usually repeated, and prolonged high-strength drops can slow surface healing. These uses are off-label, meaning no medicine is approved specifically for this condition. When drops are not enough, an eye surgeon can close off individual vessels with a fine heated needle (needle diathermy) or a laser. These work in selected people but sometimes need repeating, and laser treatment carries a small risk of thinning the cornea or bleeding. When the cornea is badly scarred, a corneal transplant can restore vision, and treating the vessels beforehand can improve the graft's chances. People with severe limbal stem cell damage may first need a stem cell transplant to rebuild the eye's surface, and an artificial cornea (keratoprosthesis) is an option after repeated graft failure.
The outlook depends mostly on what caused the vessels and how far they reach. Vessels confined to the edge of the cornea may never affect sight, while those that reach the center can cause lasting blur or glare. Catching vessel growth early, while the vessels are young, gives treatment its best chance of stopping or reversing it. Treatment is often a long process rather than a single fix. It may involve months of eye drops, repeated injections or procedures, and regular visits so the eye doctor can measure the vessels, check eye pressure if steroids are used, and watch for any return of the original problem. Shrinking the vessels does not always bring a matching improvement in vision, especially if scarring or deposits have already formed. For people who need a corneal transplant, vessels in the cornea raise the risk that the body will reject the graft or that it will fail over time, and the risk climbs with how much of the cornea is affected. Transplant planning therefore often includes treating the vessels first and closer follow-up afterward.
See an eye doctor if you notice persistent redness, irritation or blood vessels creeping onto the clear part of your eye, and keep up regular eye exams if you wear contact lenses, since lens wearers are at higher risk and early vessel growth is easy to miss. Arrange prompt assessment, ideally the same day, for a newly painful red eye, increasing light sensitivity or a noticeable drop in vision, because an active infection or flare of inflammation can drive rapid vessel growth and damage the cornea. If you have had a corneal transplant, contact your eye surgeon right away about new redness, blurred or worse vision, sensitivity to light or eye discomfort. These can be signs of rejection, and how well the graft recovers depends on starting treatment quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Corneal Neovascularization is like, what's helped you, or ask the community a question.